Evidence map›Paper›PMID 35350834›Full record

ArticleOpen medicine (Warsaw, Poland)2022

Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey.

Antonio Simone Laganà, Giovanni Veronesi, Fabio Ghezzi, Marco Mario Ferrario, Antonella Cromi, Mariano Bizzarri, Simone Garzon, Marco Cosentino

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05083065 (Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine), which is not on this map. Cited by 70 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 5 pooled it
26.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05083065 completednot on this map

Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine

TypeobservationalSponsorUniversità degli Studi dell'InsubriaRan2021 to 2021Enrolled369ConditionsCOVID-19, Vaccine, Menstrual Irregularity, Menopausal BleedingArmsCovid-19 vaccine
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 5 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Menstrual Cycle Disturbances after COVID-19 Vaccination: A Cross-Sectional Study.International journal of fertility & sterility · 2024
    Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Antonio Simone LaganàDepartment of Obstetrics and Gynecology, "Filippo Del Ponte" Hospital, University of Insubria, 21100, Varese, Italy.ORCID https://orcid.org/0000-0003-1543-2802
Giovanni VeronesiDepartment of Medicine and Surgery, School of Medicine, Research Center in Epidemiology and Preventive Medicine, University of Insubria, 21100, Varese, Italy.ORCID https://orcid.org/0000-0002-4119-6615
Fabio GhezziDepartment of Obstetrics and Gynecology, "Filippo Del Ponte" Hospital, University of Insubria, 21100, Varese, Italy.ORCID https://orcid.org/0000-0003-3949-5410
Marco Mario FerrarioDepartment of Medicine and Surgery, School of Medicine, Research Center in Epidemiology and Preventive Medicine, University of Insubria, 21100, Varese, Italy.ORCID https://orcid.org/0000-0003-2741-7124
Antonella CromiDepartment of Obstetrics and Gynecology, "Filippo Del Ponte" Hospital, University of Insubria, 21100, Varese, Italy.ORCID https://orcid.org/0000-0003-1697-5139
Mariano BizzarriDepartment of Experimental Medicine, Systems Biology Group Lab, University La Sapienza, 00161, Rome, Italy.ORCID https://orcid.org/0000-0003-0408-4136
Simone GarzonDepartment of Obstetrics and Gynaecology, AOUI Verona, University of Verona, 37126, Verona, Italy.ORCID https://orcid.org/0000-0002-5840-699X
Marco CosentinoCenter for Research in Medical Pharmacology, University of Insubria, 21100, Varese, Italy.ORCID https://orcid.org/0000-0002-6978-7775
University of Insubria · ITSapienza University of Rome · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated menstrual irregularities after the first and second doses of the COVID-19 vaccine. Women answered a customised online questionnaire (ClinicalTrial.gov ID: NCT05083065) aimed to assess the vaccine type, the phase of the menstrual cycle during which the vaccine was administered, the occurrence of menstrual irregularities after the first and second doses, and how long this effect lasted. We excluded women with gynaecological and non-gynaecological diseases, undergoing hormonal and non-hormonal treatments, in perimenopause or menopause, as well as those who had irregular menstrual cycles in the last 12 months before vaccine administration. According to our data analysis, approximately 50-60% of reproductive-age women who received the first dose of the COVID-19 vaccine reported menstrual cycle irregularities, regardless of the type of administered vaccine. The occurrence of menstrual irregularities seems to be slightly higher (60-70%) after the second dose. Menstrual irregularities after both the first and second doses of the vaccine were found to self-resolve in approximately half the cases within two months. Based on these results, we suggest to consider these elements during the counselling of women who receive the COVID-19 vaccine, letting them know about the potential occurrence of temporary and self-limiting menstrual cycle irregularities in the subsequent month(s).

Indexed as

abnormal uterine bleedingadverse effectCOVID-19menstrual irregularitiesvaccine

Identifiers

PMID35350834
PMCPMC8919838
OpenAlexW4226019128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.